S. Brienza

Long-term survival of patients with unresectable colorectal cancer liver metastases following infusional chemotherapy with 5-fluorouracil, leucovorin, oxaliplatin and surgery

Sylvie Giacchetti, M. Itzhaki, G. Gruia et al. · Annals of Oncology · 1999 · 606 citations

Surgical Oncology, Hepatology, Gastrointestinal Oncology +9

Clinical pharmacokinetics of oxaliplatin: a critical review.

Martin A. Graham, G. Lockwood, Dennis Greenslade et al. · PubMed · 2000 · 459 citations

Molecular Pharmacology, Oncology, Tumor Microenvironment +13

Two consecutive phase II studies of oxaliplatin (L-OHP) for treatment of patients with advanced colorectal carcinoma who were resistant to previous treatment with fluoropyrimidines

D. Machover, Eduardo Díaz‐Rubio, Aimery de Gramont et al. · Annals of Oncology · 1996 · 433 citations · Full text

Oncology, Medicine, Colorectal Cancer +5

A chronopharmacologic phase II clinical trial with 5-fluorouracil, folinic acid, and oxaliplatin using an ambulatory multichannel programmable pump. High antitumor effectiveness against metastatic colorectal cancer

Françis Lévi, Jean-Louis Misset, S. Brienza et al. · Cancer · 1992 · 335 citations

Phase I Trial of 5-Day Continuous Venous Infusion of Oxaliplatin at Circadian Rhythm-Modulated Rate Compared With Constant Rate

J. P. Caussanel, Francis Lévi, S. Brienza et al. · JNCI Journal of the National Cancer Institute · 1990 · 250 citations